These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4260117)

  • 21. [Report on the incidence and pathogenetic problems of drug-induced gastroduodenal lesions].
    Daniele E; De Nardo D
    Clin Ter; 1978 Apr; 85(1):47-92. PubMed ID: 350474
    [No Abstract]   [Full Text] [Related]  

  • 22. Experimental observations on flufenamic, mefenamic and meclofenamic acids. 3. Metabolic disposition.
    Glazko AJ
    Ann Phys Med; 1966; Suppl():23-36. PubMed ID: 4979052
    [No Abstract]   [Full Text] [Related]  

  • 23. [The effect of a flufenamic acid containing ointment in various rheumatic diseases. A double-blind study].
    Fotiades P; Bach GL
    Fortschr Med; 1976 Jun; 94(17):1036-8. PubMed ID: 1085738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical experience with the flufenamic acid--thyocolchicoside combination].
    López Prats JL
    Rev Esp Reum Enferm Osteoartic; 1970 Jul; 13(7):405-12. PubMed ID: 5501543
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pharmacological properties of a series of derivatives of mefenamic and flufenamic acids].
    Linari G; Spanò R
    Farmaco Sci; 1971 Apr; 26(4):303-11. PubMed ID: 5559990
    [No Abstract]   [Full Text] [Related]  

  • 26. [Use of a combination of flufenamic acid and vitamins in rheumatology].
    Lanzarini AM; Speranza M
    Clin Ter; 1970 Mar; 52(6):547-56. PubMed ID: 5452998
    [No Abstract]   [Full Text] [Related]  

  • 27. Optical studies of drug-protein complexes. V. The interaction of phenylbutazone, flufenamic acid, and dicoumarol with acetylsalicylic acid-treated human serum albumin.
    Chignell CF; Starkweather DK
    Mol Pharmacol; 1971 May; 7(3):229-37. PubMed ID: 4105907
    [No Abstract]   [Full Text] [Related]  

  • 28. [Allergic contact eczema to etofenamate and dwarf pine oil].
    Knöll R; Ulrich R; Spallek W
    Sportverletz Sportschaden; 1990 Jun; 4(2):96-8. PubMed ID: 2143316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The breast milk excretion on flufenamic acid.
    Buchanan RA; Eaton CJ; Koeff ST; Kinkel AW
    Curr Ther Res Clin Exp; 1969 Aug; 11(8):533-8. PubMed ID: 4979706
    [No Abstract]   [Full Text] [Related]  

  • 30. Experimental observations on flufenamic, mefanamic and meclofenamic acids. II. Toxicology in animals.
    Kaump DH
    Ann Phys Med; 1966; Suppl():16-23. PubMed ID: 4979051
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of acute and chronic adnexitis using flufenamic acid].
    Foix A; Creo C; Simone L; De Mayer RL
    Prensa Med Argent; 1969 Aug; 56(25):1244-7. PubMed ID: 5379733
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pharmacological properties and therapeutic effect of azapropazon in rheumatic diseases].
    Fiegel G
    Z Allgemeinmed; 1973 Apr; 49(12):592-4. PubMed ID: 4576254
    [No Abstract]   [Full Text] [Related]  

  • 33. [Flufenamic acid in the therapy of rheumatoid arthritis].
    Gigante D; Teodori S
    Clin Ter; 1968 Jul; 46(1):3-13. PubMed ID: 5703789
    [No Abstract]   [Full Text] [Related]  

  • 34. [Ant-inflammatory or antirheumatic agents? The pharmacological activity and therapeutic effectiveness of non-steroidal anti-inflammatory drugs: comparative study. I].
    Mariani L; Baratelli M
    Clin Ter; 1980 Jan; 92(2):105-26. PubMed ID: 6966996
    [No Abstract]   [Full Text] [Related]  

  • 35. [Dangerous complications of antirheumatic therapy].
    Scheibe O
    Ther Ggw; 1970 Oct; 109(10):1486 passim. PubMed ID: 5312485
    [No Abstract]   [Full Text] [Related]  

  • 36. [Practice of the treatment with anti-inflammatory agents in rheumatology].
    Laurent F
    Therapeutique; 1970 May; 46():47-8. PubMed ID: 5310589
    [No Abstract]   [Full Text] [Related]  

  • 37. Allergic dermatitis from etofenamate.
    Balato N; Lembo G; Cantelli V; Ayala F
    Contact Dermatitis; 1984 Sep; 11(3):190. PubMed ID: 6238794
    [No Abstract]   [Full Text] [Related]  

  • 38. Drug reactions. XII. Cutaneous reactions to anti-rheumatic drugs.
    Almeyda J; Baker H
    Br J Dermatol; 1970 Dec; 83(6):707-11. PubMed ID: 4250591
    [No Abstract]   [Full Text] [Related]  

  • 39. [Double-blind study using flufenamic acid (F.I. 440) and oxyphenylbutazone in rheumatoid arthritis and ankylosing spine].
    Beltrán Gutiérrez J; Fernández del Vallado P; Gijón Baños J
    Rev Esp Reum Enferm Osteoartic; 1968 Oct; 12(8):219-21. PubMed ID: 4899416
    [No Abstract]   [Full Text] [Related]  

  • 40. [Adverse effects of non-steroid anti-inflammatory agents. II. Adverse effects of derivatives of aryl-, heteroarylacetic and anthranilic acids].
    Janiec W; Pietryka B; Staniewska E; Gołek A
    Wiad Lek; 1985 Dec; 38(23):1675-80. PubMed ID: 3832647
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.